<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2687-0940</journal-id><journal-title-group><journal-title>Challenges in modern medicine</journal-title></journal-title-group><issn pub-type="epub">2687-0940</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.52575/2687-0940-2022-45-3-273-280</article-id><article-id pub-id-type="publisher-id">123</article-id><article-categories><subj-group subj-group-type="heading"><subject>STOMATOLOGY</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Manifestation of Agranulocytosis in the Oral Cavity (Clinical Case)&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Manifestation of Agranulocytosis in the Oral Cavity (Clinical Case)&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kostionova-Ovod</surname><given-names>Irina A.</given-names></name><name xml:lang="en"><surname>Kostionova-Ovod</surname><given-names>Irina A.</given-names></name></name-alternatives><email>i.a.kostionova-ovod@samsmu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Postnikov</surname><given-names>Michail A.</given-names></name><name xml:lang="en"><surname>Postnikov</surname><given-names>Michail A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Simanovskaya</surname><given-names>Oksana E.</given-names></name><name xml:lang="en"><surname>Simanovskaya</surname><given-names>Oksana E.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Trunin</surname><given-names>Dmitry A.</given-names></name><name xml:lang="en"><surname>Trunin</surname><given-names>Dmitry A.</given-names></name></name-alternatives></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Mironuk</surname><given-names>Oksana A.</given-names></name><name xml:lang="en"><surname>Mironuk</surname><given-names>Oksana A.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2022</year></pub-date><volume>45</volume><issue>3</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/journal-medicine/2022/3/273-280.pdf" /><abstract xml:lang="ru"><p>Acute agranulocytosis is a rare, potentially life-threatening condition that is associated with taking medications in more than 70&amp;nbsp;% of cases. Agranulocytosis is characterized by the number of peripheral neutrophils &amp;lt; 0.5 &amp;times; 109/l. Currently, due to the widespread use of cytotoxic therapy in medical practice, as well as the emergence of a large number of new pharmacological agents, the frequency of cases of agranulocytosis has increased significantly. Although this pathology can be found quite rarely (1&amp;nbsp;case per 1&amp;nbsp;200 people), its manifestations in the oral cavity such as ulcerative-necrotic gingivitis and stomatitis, herpetic rashes, necrosis of the tonsils, tooth mobility are a serious problem for a dentist involved in the treatment of this disease. This article will consider a clinical case of acquired agranulocytosis of a young patient against the background of taking thyrostatics, with vivid manifestations of the disease in the oral cavity. Treatment and diagnosis were carried out conscientiously by hematologists, endocrinologists and dentists, based on examination, complaints, careful collection of anamnesis and the results of additional studies. Despite the fact that acquired agranulocytosis is a rather rare disease, the described algorithms of the work carried out, supported by a photoprotocol and the results of treatment, will be relevant for dentists of all specialties, for the formation of clinical thinking and observation.</p></abstract><trans-abstract xml:lang="en"><p>Acute agranulocytosis is a rare, potentially life-threatening condition that is associated with taking medications in more than 70&amp;nbsp;% of cases. Agranulocytosis is characterized by the number of peripheral neutrophils &amp;lt; 0.5 &amp;times; 109/l. Currently, due to the widespread use of cytotoxic therapy in medical practice, as well as the emergence of a large number of new pharmacological agents, the frequency of cases of agranulocytosis has increased significantly. Although this pathology can be found quite rarely (1&amp;nbsp;case per 1&amp;nbsp;200 people), its manifestations in the oral cavity such as ulcerative-necrotic gingivitis and stomatitis, herpetic rashes, necrosis of the tonsils, tooth mobility are a serious problem for a dentist involved in the treatment of this disease. This article will consider a clinical case of acquired agranulocytosis of a young patient against the background of taking thyrostatics, with vivid manifestations of the disease in the oral cavity. Treatment and diagnosis were carried out conscientiously by hematologists, endocrinologists and dentists, based on examination, complaints, careful collection of anamnesis and the results of additional studies. Despite the fact that acquired agranulocytosis is a rather rare disease, the described algorithms of the work carried out, supported by a photoprotocol and the results of treatment, will be relevant for dentists of all specialties, for the formation of clinical thinking and observation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>agranulocytosis</kwd><kwd>ulcerative-necrotic gingivitis</kwd><kwd>thyrostatics</kwd><kwd>thiamazole</kwd></kwd-group><kwd-group xml:lang="en"><kwd>agranulocytosis</kwd><kwd>ulcerative-necrotic gingivitis</kwd><kwd>thyrostatics</kwd><kwd>thiamazole</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Chen W.T., Chi C.C. 2019. Associations of HLA genotypes with antithyroid drug-induced agranulocytosis: A systematic review and meta-analysis of pharmacogenomics studies. Br. J. Clin. Pharmacol. Sep; 85 (9): 1878&amp;ndash;1887. doi: 10.1111/bcp.13989.</mixed-citation></ref><ref id="B2"><mixed-citation>Di Fonzo H., Villegas Gutsch M., Castroagudin A., Cabrera M.V., Mazzei M.E., Rueda D. 2018. Agranulocytosis Induced by Vancomycin. Case Report and Literature Review. Am. J. Case. Rep. Sep 3; 19: 1053&amp;ndash;1056. doi: 10.12659/AJCR.909956.</mixed-citation></ref><ref id="B3"><mixed-citation>Fasullo S., Dav&amp;igrave; S., Cosenza G., Di Franco F., La Manna N., Giubilato A., Vetrano G., Maringhini G. 2018. Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature. J. Thromb. Thrombolysis. May; 45 (4): 588&amp;ndash;592. doi: 10.1007/s11239-018-1624-3.</mixed-citation></ref><ref id="B4"><mixed-citation>Garcia Del Campo C., Murcia Soler M., Martinez-Mir I., Palop Larrea V. 2021. Adecuaci&amp;oacute;n de la seguridad del metamizol y agranulocitosis [Adequacy of the safety of metamizole and agranulocytosis]. Aten Primaria. Jun-Jul; 53&amp;nbsp;(6):&amp;nbsp;102047. Spanish. doi: 10.1016/j.aprim.2021.102047.</mixed-citation></ref><ref id="B5"><mixed-citation>Genchanok Y., Tolu S.S., Wang H., Arora S. 2019. Agranulocytosis from Outpatient Antimicrobial Treatment with Ceftriaxone: A Case Report. Perm. J. 2019; 23: 18&amp;ndash;190. doi: 10.7812/TPP/18-190.</mixed-citation></ref><ref id="B6"><mixed-citation>Gonnert F.A., Mei&amp;szlig;ner W. 2018. Kasuistik: Metamizol-induzierte Agranulozytose [Case Report &amp;ndash; Metamizole-Induced Agranulocytosis]. Anasthesiol Intensivmed Notfallmed Schmerzther. May; 53&amp;nbsp;(5): 388&amp;ndash;394 (in German). doi: 10.1055/s-0043-115329.</mixed-citation></ref><ref id="B7"><mixed-citation>Kılı&amp;ccedil; &amp;Ouml;., İşeri Nepesov M., Ulukapı H.B., &amp;Ouml;zdemir Z.C., B&amp;ouml;r &amp;Ouml;., Dinleyici E.&amp;Ccedil;. 2021. Paediatric Agranulocytosis Associated with Metamizole Treatment. Paediatr Drugs. Jan; 23 (1): 105&amp;ndash;110. doi: 10.1007/s40272-020-00431-1.</mixed-citation></ref><ref id="B8"><mixed-citation>Lhomme F., Ochmann M., Lamy T. 2015. Agranulocytose m&amp;eacute;dicamenteuse [Drug-induced agranulocytosis]. Rev Prat. May; 65 (5): 697&amp;ndash;700 (in French).</mixed-citation></ref><ref id="B9"><mixed-citation>Lopes V., Ramos J., Dias P., Santos A. 2021. Nitrofurantoin-induced agranulocytosis. B.M.J. Case. Rep. Nov 11; 14 (11): e246788. doi: 10.1136/bcr-2021-246788.</mixed-citation></ref><ref id="B10"><mixed-citation>McCulloch J.E., Miller A., Borcea M., Reid J. 2021. Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19. B.M.J. Case. Rep. Jan 6; 14 (1): e239355. doi: 10.1136/bcr-2020-239355.</mixed-citation></ref><ref id="B11"><mixed-citation>Mijovic A., MacCabe J.H. 2020. Clozapine-induced agranulocytosis. Ann. Hematol. Nov; 99 (11): 2477&amp;ndash;2482. doi: 10.1007/s00277-020-04215-y.</mixed-citation></ref><ref id="B12"><mixed-citation>Patel R., Lima A., Burke C., Hoffman M. 2019. Monocytopenia in clozapine-induced agranulocytosis: insights into pathophysiology and treatment. B.M.J. Case. Rep. Jan 18; 12 (1): bcr-2018-226016. doi: 10.1136/bcr-2018-226016.</mixed-citation></ref><ref id="B13"><mixed-citation>Rib&amp;eacute; Buitr&amp;oacute;n J.M., Gonz&amp;aacute;lez Rodr&amp;iacute;guez M., Barcel&amp;oacute; Colomer M.E. 2021. Clozapina y agranulocitosis: repensando la utilidad de su monitorizaci&amp;oacute;n [Clozapine and agranulocytosis: Rethinking the usefulness of its monitoring]. Aten Primaria. Oct; 53 (8): 102114 (in Spanish). doi: 10.1016/j.aprim.2021.102114.</mixed-citation></ref><ref id="B14"><mixed-citation>Schinz K., Waldfahrer F., W&amp;uuml;st W., Iro H. 2020. Agranulozytose nach Metamizol-Einnahme &amp;ndash; ein untersch&amp;auml;tztes Risiko? [Agranulocytosis after use of metamizole &amp;ndash; an underestimated risk?]. Laryngorhinootologie. Oct; 99 (10): 707&amp;ndash;712. (in German). doi: 10.1055/a-1190-4445.</mixed-citation></ref><ref id="B15"><mixed-citation>Stern A., Carrara E., Bitterman R., Yahav D., Leibovici L., Paul M. 2019. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer. Cochrane Database Syst. Rev. Jan 3; 1 (1): CD012184. doi: 10.1002/14651858.</mixed-citation></ref><ref id="B16"><mixed-citation>Thompson R.A., Isin E.M., Ogese M.O., Mettetal J.T., Williams D.P. 2016. Reactive metabolites: current and emerging risk and hazard assessments. Chem. Res. Toxicol. 29 (4): 505&amp;ndash;533.</mixed-citation></ref><ref id="B17"><mixed-citation>Tunsirimas N., Pariwatcharakul P., Choovanichvong S., Ratta-Apha W. 2019. Clozapine-induced agranulocytosis and leukopenia: Incidence, associated factors, and rate of hematologic adverse-effects monitoring in psychiatric out-patient services in Thailand. Asian J. Psychiatr. Mar; 41: 13&amp;ndash;16. doi: 10.1016/j.ajp.2019.03.002.</mixed-citation></ref><ref id="B18"><mixed-citation>Vicente N., Cardoso L., Barros L., Carrilho F. 2017. Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management. Drugs R. D. Mar; 17 (1): 91&amp;ndash;96. doi: 10.1007/s40268-017-0172-1.</mixed-citation></ref><ref id="B19"><mixed-citation>Wiciński M., Węclewicz M.M. 2018. Clozapine-induced agranulocytosis/granulocytopenia: mechanisms and monitoring. Curr. Opin. Hematol. Jan; 25&amp;nbsp;(1): 22&amp;ndash;28. doi: 10.1097/MOH.0000000000000391</mixed-citation></ref><ref id="B20"><mixed-citation>Zhu D., Zhang S., Cao X., Xia Q., Zhang Q., Deng D., Gao S., Yu H., Liu Y., Zhou H., Tao F., Sun X. 2021. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism. Endocr. Pract. Dec; 27 (12): 1183&amp;ndash;1188. doi: 10.1016/j.eprac.2021.06.017</mixed-citation></ref></ref-list></back></article>